PPARG and atherosclerosis: Thiazolidinediones (TZDs), which are some of the most common PPARγ ligands, are insulin-sensitizing antidiabetic agents causing the improvement of hypertension and hypertriglyceridemia, both of which represent major risk factors for atherosclerosis.